Affiliation:
1. Department of Neurology Medical University of Innsbruck Innsbruck Austria
2. Department of Gynecological Endocrinology and Reproductive Medicine Medical University of Innsbruck Innsbruck Austria
3. Department of Statistics, Faculty of Economics and Statistics University of Innsbruck Innsbruck Austria
4. Central Institute of Medical and Chemical Laboratory Diagnostics (ZIMCL) University Hospital of Innsbruck Innsbruck Austria
Abstract
AbstractBackground and purposeSexual dysfunction (SD) in people with multiple sclerosis (pwMS) is common and an often underestimated issue in the care of pwMS. The objective of the study was to evaluate risk factors for SD in pwMS, correlate its prevalence with patient‐reported measures (quality of life and physical activity) and analyse its association with hormonal status.MethodsSexual dysfunction was determined in 152 pwMS using the Multiple Sclerosis Intimacy and Sexuality Questionnaire 19. A logistical regression model was used to identify independent risk factors for SD.ResultsThe prevalence of SD in pwMS was 47%. Independent risk factors for the development of SD were ever‐smoking (odds ratio [OR] 3.4, p = 0.023), disability as measured by the Expanded Disability Status Scale (OR 2.0, p < 0.001), depression (OR 4.3, p = 0.047) and bladder and bowel dysfunction (OR 8.8, p < 0.001); the use of disease‐modifying treatment was associated with a lower risk for SD (OR 0.32, p = 0.043). SD was associated with worse quality of life (Multiple Sclerosis Impact Scale 29: physical score 6.3 vs. 40.0; psychological score 8.3 vs. 33.3; both p < 0.001) and lower physical activity (Baecke questionnaire, p < 0.001). Laboratory analysis revealed significantly higher luteinizing hormone and follicle‐stimulating hormone levels and lower 17‐beta oestradiol, androstenedione, dehydroepiandrosterone sulfate, oestrone and anti‐Mullerian hormone levels in female pwMS with SD. In male pwMS and SD, there was a significant decrease in inhibin B levels.ConclusionsOur findings highlight the requirement of a holistic approach to SD in MS including physical, neurourological and psychosocial factors. Active screening for SD, especially in patients with disability, depression or bladder and bowel dysfunction, is recommended.
Subject
Neurology (clinical),Neurology
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献